 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
International News WHO Approves Four New Indian Drugs for HIVJuly 14, 2004 On Tuesday, the World Health Organization approved four new generic Indian-produced drugs for HIV treatment. The four drugs are 150-mg lamivudine, made by Strides, and Cipla's 50-mg, 150-mg and 200-mg fluconazole, an antifungal. The lamivudine tablet is an alternative to Cipla's product, recently delisted because the laboratory that performed analysis to confirm the drug's efficacy did not meet international standards. WHO said the drugs will be added to its prequalification list this week. Associated Press 07.13.04  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Site Policies | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
